Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1539-0829
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Harnessing Metabolomics to Describe the Pathophysiology Underlying Progression in Diabetic Kidney Disease ; volume:21 ; number:7 ; day:11 ; month:5 ; year:2021 ; pages:1-6 ; date:7.2021
Current diabetes reports ; 21, Heft 7 (11.5.2021), 1-6, 7.2021
- Urheber
-
Hasegawa, Sho
Inagi, Reiko
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s11892-021-01390-8
- URN
-
urn:nbn:de:101:1-2021092121145958427036
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:28 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Hasegawa, Sho
- Inagi, Reiko
- SpringerLink (Online service)
Ähnliche Objekte (12)
Stroke Related Brain–Heart Crosstalk: Pathophysiology, Clinical Implications, and Underlying Mechanisms
Visual snow syndrome after start of citalopram—novel insights into underlying pathophysiology
Towards soundscape fingerprinting: development, analysis and assessment of underlying acoustic dimensions to describe acoustic environments
Emerging proteomic approaches to identify the underlying pathophysiology of neurodevelopmental and neurodegenerative disorders
Understanding CT imaging findings based on the underlying pathophysiology in patients with small bowel ischemia
Nontargeted metabolomics reveals the potential mechanism underlying the association between birthweight and metabolic disturbances
When Should We Describe Species?
Metabolomics
Identifying the etiology and pathophysiology underlying stunting and environmental enteropathy: study protocol of the AFRIBIOTA project
Glycerophospholipid and detoxification pathways associated with small for gestation age pathophysiology: discovery metabolomics analysis in the SCOPE cohort
Evaluating functions to describe point patterns
Using ontologies to describe mouse phenotypes
Stroke Related Brain–Heart Crosstalk: Pathophysiology, Clinical Implications, and Underlying Mechanisms
Visual snow syndrome after start of citalopram—novel insights into underlying pathophysiology
Towards soundscape fingerprinting: development, analysis and assessment of underlying acoustic dimensions to describe acoustic environments
Emerging proteomic approaches to identify the underlying pathophysiology of neurodevelopmental and neurodegenerative disorders
Understanding CT imaging findings based on the underlying pathophysiology in patients with small bowel ischemia
Nontargeted metabolomics reveals the potential mechanism underlying the association between birthweight and metabolic disturbances
When Should We Describe Species?
Metabolomics
Identifying the etiology and pathophysiology underlying stunting and environmental enteropathy: study protocol of the AFRIBIOTA project
Glycerophospholipid and detoxification pathways associated with small for gestation age pathophysiology: discovery metabolomics analysis in the SCOPE cohort
Evaluating functions to describe point patterns
Using ontologies to describe mouse phenotypes
Stroke Related Brain–Heart Crosstalk: Pathophysiology, Clinical Implications, and Underlying Mechanisms
Visual snow syndrome after start of citalopram—novel insights into underlying pathophysiology
Towards soundscape fingerprinting: development, analysis and assessment of underlying acoustic dimensions to describe acoustic environments
Emerging proteomic approaches to identify the underlying pathophysiology of neurodevelopmental and neurodegenerative disorders
Understanding CT imaging findings based on the underlying pathophysiology in patients with small bowel ischemia
Nontargeted metabolomics reveals the potential mechanism underlying the association between birthweight and metabolic disturbances
When Should We Describe Species?
Metabolomics
Identifying the etiology and pathophysiology underlying stunting and environmental enteropathy: study protocol of the AFRIBIOTA project
Glycerophospholipid and detoxification pathways associated with small for gestation age pathophysiology: discovery metabolomics analysis in the SCOPE cohort
Evaluating functions to describe point patterns